Literature DB >> 2967864

Autoimmune thyroiditis induced in mice depleted of particular T cell subsets. I. Requirement of Lyt-1 dull L3T4 bright normal T cells for the induction of thyroiditis.

S Sugihara1, Y Izumi, T Yoshioka, H Yagi, T Tsujimura, O Tarutani, Y Kohno, S Murakami, T Hamaoka, H Fujiwara.   

Abstract

T cell-depleted C3H/He or (C57BL/6xC3H/He)F1 (B6C3F1) mice were prepared by adult thymectomy and injection of antithymocyte serum, followed 3 wk later by lethal x-irradiation and bone marrow reconstitution. When these T cell-depleted mice were not injected or injected i.v. with normal spleen and lymph node cells treated with either anti-Thy-1, -L3T4 or -Lyt-2 antibody plus C or C alone, none of the groups of mice developed thyroiditis. In contrast, the adoptive transfer of normal cells treated with anti-Lyt-1 plus C resulted in high incidence of the production of antithyroglobulin antibody and the induction of typical thyroiditis lesion. The thyroid was the sole organ involved, because neither typical inflammatory lesion in other organs nor autoantibody such as anti-DNA antibody was detected in mice that exhibited thyroiditis. Analyses of surface phenotypes of cells required for inducing thyroiditis by the adoptive transfer revealed that an appreciable percentage of Lyt-1 dull T cells remained after the treatment of normal lymphoid cells with anti-Lyt-1 plus C. Almost all of these Lyt-1 dull T cells expressed magnitudes of L3T4 or Lyt-2 Ag comparable to those detected on Lyt-1 bright T cells. More important, the induction of thyroiditis was almost completely prevented by either in vitro or in vivo elimination of Lyt-1 dull L3T4+(bright) but not of Lyt-1 dull Lyt-2+(bright) T cells. These results indicate that Lyt-1 dull L3T4+ T cells existing in normal healthy individuals have potential to induce typical thyroiditis which is associated with the production of antithyroglobulin autoantibody, and that the activation and/or function of this T cell subset is regulated by the Lyt-1 bright T cell population coexisting in normal lymphoid cell population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967864

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-28       Impact factor: 11.205

2.  Regulation of experimental autoimmune orchitis by the presence or absence of testicular antigens during immunological development in SCID mice reconstituted with fetal liver cells.

Authors:  A Wakabayashi; Y Eishi; K Nakamura
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

3.  Multiple immuno-regulatory defects in type-1 diabetes.

Authors:  Anjli Kukreja; Giulia Cost; John Marker; Chenhui Zhang; Zhong Sun; Karen Lin-Su; Svetlana Ten; Maureen Sanz; Mark Exley; Brian Wilson; Steven Porcelli; Noel Maclaren
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  Elimination of CD4(+)CD25(+) T cell accelerates the development of glomerulonephritis during the preactive phase in autoimmune-prone female NZB x NZW F mice.

Authors:  Toshiharu Hayashi; Keiko Hasegawa; Chie Adachi
Journal:  Int J Exp Pathol       Date:  2005-10       Impact factor: 1.925

5.  Pathogenic mechanisms in murine autoimmune thyroiditis: short- and long-term effects of in vivo depletion of CD4+ and CD8+ cells.

Authors:  Y M Kong; H Waldmann; S Cobbold; A A Giraldo; B E Fuller; L L Simon
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

6.  Total colectomy improves altered distribution of regulatory T cells in patients with ulcerative colitis.

Authors:  Makoto Furihata; Tokihiko Sawada; Toshie Okada; Mitsuru Ishizuka; Toru Horie; Kazutoshi Takagi; Hitoshi Nagata; Keiichi Kubota
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

7.  Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.

Authors:  S Hori; S Kitagawa; H Iwata; T Ochiai; K Isono; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

8.  Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.

Authors:  S Kitagawa; H Iwata; S Sato; J Shimizu; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

9.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.

Authors:  M Asano; M Toda; N Sakaguchi; S Sakaguchi
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.

Authors:  Ping Yu; Youjin Lee; Wenhua Liu; Thomas Krausz; Anita Chong; Hans Schreiber; Yang-Xin Fu
Journal:  J Exp Med       Date:  2005-03-07       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.